BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 16255745)

  • 1. Kinetics of immunoglobulin G, M, A and IgG subclass responses in experimental intravaginal trichomoniasis: prominence of IgG1 response.
    Yadav M; Gupta I; Malla N
    Parasite Immunol; 2005 Dec; 27(12):461-7. PubMed ID: 16255745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of serum and local cytokine profile in experimental intravaginal trichomoniasis induced with Trichomonas vaginalis isolates from symptomatic and asymptomatic women.
    Malla N; Yadav M; Gupta I
    Parasite Immunol; 2007 Feb; 29(2):101-5. PubMed ID: 17241398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific IgA response, T-cell subtype and cytokine profile in experimental intravaginal trichomoniasis.
    Paintlia MK; Kaur S; Gupta I; Ganguly NK; Mahajan RC; Malla N
    Parasitol Res; 2002 Apr; 88(4):338-43. PubMed ID: 11999021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitrichomonas IgG, IgM, IgA, and IgG subclass responses in human intravaginal trichomoniasis.
    Kaur S; Khurana S; Bagga R; Wanchu A; Malla N
    Parasitol Res; 2008 Jul; 103(2):305-12. PubMed ID: 18437425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine proteinase 30 (CP30) and antibody response to CP30 in serum and vaginal washes of symptomatic and asymptomatic Trichomonas vaginalis-infected women.
    Yadav M; Dubey ML; Gupta I; Malla N
    Parasite Immunol; 2007 Jul; 29(7):359-65. PubMed ID: 17576365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody isotypes in urethral swabs of symptomatic and asymptomatic men infected with Trichomonas vaginalis.
    Imam NF; Eassa AH; Shoeib EY; Abo-Raia GY
    J Egypt Soc Parasitol; 2007 Dec; 37(3):977-88. PubMed ID: 18383797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro comparative kinetics of adhesive and haemolytic potential of T. vaginalis isolates from symptomatic and asymptomatic females.
    Valadkhan Z; Sharma S; Harjai K; Gupta I; Malla N
    Indian J Pathol Microbiol; 2003 Oct; 46(4):693-9. PubMed ID: 15025385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide radicals in leucocytes and vaginal washes of Trichomonas vaginalis -infected symptomatic and asymptomatic women.
    Yadav M; Dubey ML; Gupta I; Malla N
    Parasitology; 2006 Mar; 132(Pt 3):339-43. PubMed ID: 16529664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of intravaginal microbicides to prevent acquisition of Trichomonas vaginalis infection in Lactobacillus-pretreated, estrogenized young mice.
    Lushbaugh WB; Blossom AC; Shah PH; Banga AK; Jaynes JM; Cleary JD; Finley RW
    Am J Trop Med Hyg; 2000; 63(5-6):284-9. PubMed ID: 11421379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteine proteinase 30 in clinical isolates of T. vaginalis from symptomatic and asymptomatic infected women.
    Yadav M; Dubey ML; Gupta I; Bhatti G; Malla N
    Exp Parasitol; 2007 Aug; 116(4):399-406. PubMed ID: 17420015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between Trichomonas vaginalis and vaginal flora in a mouse model.
    Meysick KC; Garber GE
    J Parasitol; 1992 Feb; 78(1):157-60. PubMed ID: 1310732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme linked immunosorbent assay for detecting antibody to Trichomonas vaginalis: use of whole cells and aqueous extract as antigen.
    Alderete JF
    Br J Vener Dis; 1984 Jun; 60(3):164-70. PubMed ID: 6610453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal immunisation with a 62 kDa proteinase combined with cholera toxin or CpG adjuvant protects against Trichomonas vaginalis genital tract infections in mice.
    Hernández HM; Figueredo M; Garrido N; Sánchez L; Sarracent J
    Int J Parasitol; 2005 Nov; 35(13):1333-7. PubMed ID: 16202417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pathogenicity of trichomonas vaginalis isolated from symptomatic & asymptomatic cases.
    Bhatt R; Deodhar L; Pandit D; Bhise R; Chatterjee DK
    J Postgrad Med; 1997; 43(3):68-70. PubMed ID: 10740726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genital and systemic immune responses in a murine model of Tritrichomonas foetus infection.
    Mutwiri GK; Corbeil LB
    J Parasitol; 1998 Apr; 84(2):321-7. PubMed ID: 9576506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echinostoma caproni: kinetics of IgM, IgA and IgG subclasses in the serum and intestine of experimentally infected rats and mice.
    Sotillo J; Muñoz-Antoli C; Marcilla A; Fried B; Guillermo Esteban J; Toledo R
    Exp Parasitol; 2007 Aug; 116(4):390-8. PubMed ID: 17418820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity.
    Malla N; Kaul P; Sehgal R; Gupta I
    Indian J Med Microbiol; 2011; 29(2):152-7. PubMed ID: 21654110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody to Trichomonas vaginalis in human cervicovaginal secretions.
    Su KE
    Infect Immun; 1982 Sep; 37(3):852-7. PubMed ID: 6982231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pathogenicity of Trichomonas vaginalis isolated from symptomatic and asymptomatic cases.
    Bhatt R; Pandit D; Deodhar L; Bhise R; Chatterjee DK
    J Postgrad Med; 1993; 39(4):187-9. PubMed ID: 7996493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
    Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS
    Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.